Close Menu

NEW YORK – Bio-Rad Laboratories said after the close of the market on Thursday that its fourth quarter revenues rose approximately 1 percent year over year.

For the three months ended Dec. 31, 2019, the Hercules, California-based firm reported $624.4  million in revenues compared to $616.8 million in the year-ago period. On a currency-neutral basis, quarterly revenues increased approximately 2 percent year over year. On average, analysts had expected revenues of $642.0 million for the quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.